Pharmacy Daily | Stumping cancer

A NEW study has found that gamma-tocotrienol (GT) is effective in targeting prostate cancer stem cells and wiping them out. Researchers at the Australian Prostate Cancer Research Centre, in conjunction with Davos Life Science and the University of Hong Kong found that gammatocotrienol (a member of the Vitamin E family which is derived from Palm Oil) found that low doses of GT killed prostate cancer stem cells, and also suppressed the cells colony formation capabilities. The researchers also found that when orally administered to mice who had been implanted with hormonal refractory prostate cancer cells, GT decreased the incidence rate of tumor formation by 75% and was also effective in reducing the size of tumors that did form. “The prospects of future studies on the cancer-fighting effects of gamma-tocotrienols are exciting indeed and we see increasing research interest by scientists in this area,” said Mr. Arthur Ling, ceo of Davos Life Science Singapore.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 10